Vale SA
VALE
D.R. Horton
DHI
Taylor Morrison Home
TMHC
Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
US Stock MarketDetailed Quotes
TCDAQ TRICIDA INC
- 0.000010
- 0.0000000.00%
15min DelayClose Aug 8 16:00 ET
580.28Market Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000010Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)58.03MShares0.00001052wk High0.00P/B335.93Float Cap0.00001052wk Low--Dividend TTM33.59MShs Float44.300000Historical High--Div YieldTTM0.00%Amplitude0.000010Historical Low--Avg Price1Lot Size
About TRICIDA INC Company
Tricida Inc is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis.
Company Profile
SymbolTCDAQ
Company NameTRICIDA INC
CEODr. Gerrit Klaerner, PhD.
MarketPink Market
Employees57
Fiscal Year Ends12-31
Websitehttps://www.tricida.com
Company Executives
- Name
- Position
- Salary
- Dr. Gerrit Klaerner, PhD.
- Director, President and Chief Executive Officer
- --
- Annie Yoshiyama
- Vice President, Finance and Chief Accounting Officer
- --
- Geoffrey M. Parker
- Chief Operating Officer, Chief Financial Officer and Executive Vice President
- --
- Robert McKague
- Executive Vice President, General Counsel and Chief Compliance Officer
- --
- Dr. Dawn Parsell
- Executive Vice President, Clinical Development
- --
- Dr. Klaus Veitinger, M.D.,PhD
- Chairman of the Board
- --
- Dr. David P. Bonita, M.D.
- Independent Director
- --
- Dr. David Hirsch, M.D.,PhD
- Independent Director
- --
- Thomas G. FitzGerald
- Independent Director
- --
- Sandra I Coufal
- Independent Director
- --
- Kathryn E. Falberg
- Independent Director
- --
- Dr. Robert J. Alpern,M.D.
- Independent Director
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.